<DOC>
	<DOCNO>NCT01635023</DOCNO>
	<brief_summary>Study Healthy Males Compare White Blue Formulations AZD6244 .</brief_summary>
	<brief_title>A Randomized , Open Label Study Compare Current Phase II Planned Phase III Capsule Formulation AZD6244</brief_title>
	<detailed_description>A Phase I , Single-center , Randomized , Open-label , Crossover Study Compare White ( Current Phase II ) Blue ( Planned Phase III ) Capsule Formulations AZD6244 Hyd-Sulfate Healthy Male Subjects .</detailed_description>
	<criteria>Healthy male volunteer age 18 55 BMI 18 30 kg/m2 inclusive weigh least 50 kg 100 kg , inclusive Calculated creatinine clearance ( CRCL ) great 50 mL/min usin gthe CockcroftGault formula History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism , exertion drug . Any positive result screen serum hepatitis B surface antigen , hepatitis C antibody , HIV . Any clinically important abnormality rhythm , conduction , morphology rest dECG clinically important abnormality 12lead dECG suggest cardiac , metabolic noncardiac condition . Current past history central serous retinopathy retinal vein thrombosis , intraocular pressure great 21 mmHg uncontrolled glaucoma Known suspect history drug abuse , current smoke smoke use nicotinecontaining product within previous 3 month</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Phase I</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>AZD6244</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>AUC</keyword>
	<keyword>Cmax</keyword>
	<keyword>tmax</keyword>
	<keyword>AUC ( 0-t )</keyword>
</DOC>